REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1581659
Review of the Ethnobotany, Phytochemistry, Pharmacology, and Toxicity studies of the Genus Adenia
Provisionally accepted- Tshwane University of Technology, Pretoria, South Africa
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The genus Adenia has a rich history of traditional medicinal use across various cultures, particularly in Africa and parts of Asia. The present review summarizes key features of the genus Adenia, focusing on its occurrence, distribution, isolation, bioactivities, and toxicities.A thorough literature review was conducted using databases such as Google Scholar, PubMed, ScienceDirect, JSTOR, and Web of Science. The search utilized the keyword "Adenia" in combination with relevant terms like "distribution," "traditional use," "phytochemicals," "chemical compounds," "pharmacology," "bioactivity," and "toxicity."Results: Our search yielded 3724 records, with 88 studies from 1935 to 2024 meeting our criteria. The findings indicate that the genus Adenia comprises over 106 species of climbing plants, commonly found in tropical and subtropical regions. In traditional medicine, several Adenia species have been employed in various cultures for medicinal purposes, treating ailments such as wounds, leprosy, malaria, infections, infertility, colic, dysentery, hypertension, rheumatism, headaches, abdominal pain, and cancer. Chemical investigations have identified 27 secondary metabolites including alkaloids, glycosides, flavonoids, and ribosome-inactivating proteins (RIPs), particularly type 2, which are associated with cytotoxic and toxic effects. Pharmacological studies of chemical constituents and extracts from Adenia species have revealed a broad spectrum of biological activities, including cytotoxicity, antimicrobial, antioxidant, anti-inflammatory, analgesic, anticholinesterase, neuropharmacological, antidepressant, antihyperglycaemic, anti-anemic, anticoagulant, antithrombotic, thrombolytic, and anesthetic activities. Despite their therapeutic benefits, concerns regarding safety and toxicity are significant, necessitating comprehensive evaluations and standardized methodologies for assessing their efficacy. Thus, future research should focus on validating the traditional uses of Adenia species through rigorous scientific methods to ensure their safety and efficacy in modern medicine.
Keywords: Adenia, Ethnobotany, bioactive compounds, Pharmacology, ribosome-inactivating proteins, Toxicity, traditional medicine
Received: 22 Feb 2025; Accepted: 23 Apr 2025.
Copyright: © 2025 Mouafon Lah and Katerere. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Iliassou Mouafon Lah, Tshwane University of Technology, Pretoria, South Africa
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.